Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Circulatory Collapse

glucose, (beta-d)-isomer has been researched along with Circulatory Collapse in 30 studies

Research

Studies (30)

TimeframeStudies, this research(%)All Research%
pre-19902 (6.67)18.7374
1990's11 (36.67)18.2507
2000's13 (43.33)29.6817
2010's4 (13.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buharalioglu, CK; Guden, DS; Kacan, M; Korkmaz, B; Malik, KU; Sahan-Firat, S; Sari, AN; Tamer-Gumus, L; Temiz-Resitoglu, M; Tunctan, B; Unsal, D; Yildirim-Yaroglu, H1
Huang, Z; Liu, C; Liu, S; Liu, Y; Pang, Q; Song, S; Wu, Q; Zhang, J; Zhang, R1
Bramanti, P; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Salvemini, D1
Capuano, A; Cuzzocrea, S; Di Palma, D; Donniacuo, M; Esposito, E; Mazzon, E; Paterniti, I; Rinaldi, B; Rossi, F; Sodano, L1
Bramanti, P; Cuzzocrea, S; Di Paola, R; Impellizzeri, D; Mazzon, E; Paterniti, I1
Blask, D; Dauchy, R; Dietz, PA; Lynch, D; Reynolds, FD; Zuckerman, R1
Caputi, AP; Cuzzocrea, E; Cuzzocrea, S; Di Paola, R; Dugo, L; Fulia, F; Genovese, T; Mazzon, E; Salvemini, D; Serraino, I1
Caputi, AP; Chatterjee, PK; Cuzzocrea, E; Cuzzocrea, S; Di Paola, R; Di Rosa, M; Dugo, L; Fulia, F; Genovese, T; Ianaro, A; Patel, NS; Pisano, B; Thiemermann, C1
Autore, G; Britti, D; Cuzzocrea, S; Di Paola, R; Genovese, T; Marzocco, S; Pinto, A; Scollo, G; Sorrentino, R1
Caputi, AP; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Genovese, T; Mazzon, E; Muià, C; Patel, NS; Thiemermann, C1
Crisafulli, C; Cuzzocrea, S; Di Bella, P; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Meli, R; Menegazzi, M; Muià, C; Suzuki, H1
Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Malleo, G; Mazzon, E; Meli, R; Muià, C; Sessa, E1
Abdelrahman, M; Crisafulli, C; Cuzzocrea, S; Di Paola, R; Esposito, E; Genovese, T; Mazzon, E; Muià, C; Thiemermann, C1
Thiemermann, C1
Dimitrova, P; Remichkova, M; Yordanov, M1
Dimitrova, PA; El-Rachkidy Lonnen, R; Ivanovska, ND; Luckett, JC; Schwaeble, WJ; Stover, CM1
Phair, JP; Venezio, FR; Westenfelder, GO1
Caputi, AP; Cuzzocrea, S; Falciani, M; Filippelli, A; Rossi, F; Zingarelli, B1
Caputi, AP; Cuzzocrea, S; Zingarelli, B1
Dwenger, A; Grotz, M; Pape, HC; Remmers, D; Tscherne, H; Vaske, R; Wisner, D1
Caputi, AP; Costantino, G; Cuzzocrea, S2
Cuzzocrea, S; Filippelli, A; Imperatore, F; Luongo, C; Mangoni, G; Portolano, F; Rossi, F; Scafuro, MA1
Caputi, AP; Ciriaco, E; Costantino, G; Cuzzocrea, S; de Sarro, A; de Sarro, G; Laurà, R; Mazzon, E1
Caputi, AP; Cuzzocrea, S; El-Sokkary, GH; Hassanein, AF; Reiter, RJ; Tan, DX1
Caputi, AP; Costantino, G; Cuzzocrea, S; De Sarro, A; Mazzon, E1
Barbera, A; Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Dugo, L; Fonti, MT; Mazzon, E1
Joyce, L; Lillehei, R; Mauer, H; Smith, J1
Gershon, D; Lavie, L; Weinreb, O1
Bahrami, S; Goris, RJ; Lieners, C; Redl, H; Schlag, G; van Bebber, IP1

Other Studies

30 other study(ies) available for glucose, (beta-d)-isomer and Circulatory Collapse

ArticleYear
The role of Syk/IĸB-α/NF-ĸB pathway activation in the reversal effect of BAY 61-3606, a selective Syk inhibitor, on hypotension and inflammation in a rat model of zymosan-induced non-septic shock.
    Clinical and experimental pharmacology & physiology, 2018, Volume: 45, Issue:2

    Topics: Animals; Gene Expression Regulation; I-kappa B Kinase; Male; NF-kappa B; Niacinamide; Pyrimidines; Rats; Rats, Wistar; Shock; Syk Kinase; Zymosan

2018
Role of Serotonin in MODS: Deficiency of Serotonin Protects Against Zymosan-Induced Multiple Organ Failure in Mice.
    Shock (Augusta, Ga.), 2015, Volume: 43, Issue:3

    Topics: 5-Hydroxytryptophan; Animals; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Fenclonine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; Oxidative Stress; Peritonitis; Protective Agents; Serotonin; Shock; Tryptophan Hydroxylase; Zymosan

2015
Fumonisin b1 reduces the development of multiple organ failure induced by zymosan in mice.
    Shock (Augusta, Ga.), 2009, Volume: 31, Issue:2

    Topics: Animals; Cytokines; Fumonisins; Immunohistochemistry; Inflammation; Male; Mice; Multiple Organ Failure; Nitric Oxide; Peritonitis; Peroxidase; Shock; Time Factors; Treatment Outcome; Zymosan

2009
PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure.
    British journal of pharmacology, 2011, Volume: 163, Issue:3

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1beta; Intestinal Mucosa; Intestines; Kidney; Liver; Lung; Mice; Mice, Knockout; Multiple Organ Failure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR alpha; Shock; Simvastatin; Tumor Necrosis Factor-alpha; Up-Regulation; Zymosan

2011
Effect of NADPH-oxidase inhibitors in the experimental model of zymosan-induced shock in mice.
    Free radical research, 2011, Volume: 45, Issue:7

    Topics: Acetophenones; Animals; Apoptosis; Cytokines; Enzyme Inhibitors; Male; Mice; Multiple Organ Failure; NADPH Oxidases; Nitrates; Nitrites; Onium Compounds; Reactive Oxygen Species; Shock; Systemic Inflammatory Response Syndrome; Zymosan

2011
The pineal gland hormone melatonin improves survival in a rat model of sepsis/shock induced by zymosan A.
    Surgery, 2003, Volume: 134, Issue:3

    Topics: Animals; Disease Models, Animal; Male; Melatonin; Multiple Organ Failure; Rats; Rats, Sprague-Dawley; Sepsis; Shock; Zymosan

2003
Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock.
    Critical care medicine, 2004, Volume: 32, Issue:1

    Topics: Animals; Disease Models, Animal; Immunohistochemistry; Intestines; Lipid Peroxidation; Lung; Male; Multiple Organ Failure; Organometallic Compounds; Probability; Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Risk Assessment; Sensitivity and Specificity; Shock; Statistics, Nonparametric; Superoxide Dismutase; Zymosan

2004
Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Critical care medicine, 2004, Volume: 32, Issue:2

    Topics: Animals; Lipid Peroxidation; Male; Mice; Multiple Organ Failure; Nitric Oxide; Nitrosation; Rosiglitazone; Shock; Thiazolidinediones; Zymosan

2004
Methylguanidine reduces the development of non septic shock induced by zymosan in mice.
    Life sciences, 2004, Aug-06, Volume: 75, Issue:12

    Topics: Analysis of Variance; Animals; Disease Models, Animal; Exudates and Transudates; Immunohistochemistry; Intestinal Mucosa; Intestines; Kidney; Lipid Peroxidation; Lung; Male; Methylguanidine; Mice; Neutrophils; Pancreas; Peritonitis; Peroxidase; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Shock; Tyrosine; Zymosan

2004
Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice.
    Critical care medicine, 2006, Volume: 34, Issue:4

    Topics: Animals; Erythropoietin; Male; Mice; Shock; Zymosan

2006
Green tea polyphenol extract attenuates zymosan-induced non-septic shock in mice.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:4

    Topics: Animals; Camellia sinensis; Flavonoids; Male; Mice; Phenols; Phytotherapy; Plant Extracts; Polyphenols; Shock; Weight Loss; Zymosan

2006
Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
    Shock (Augusta, Ga.), 2006, Volume: 26, Issue:5

    Topics: Animals; Apoptosis; Fas Ligand Protein; Inflammation; Intestines; Kidney; Lipid Peroxidation; Mice; Mice, Knockout; Multiple Organ Failure; Neutrophil Infiltration; Nitric Oxide; PPAR alpha; Shock; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation; Zymosan

2006
Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice.
    Shock (Augusta, Ga.), 2007, Volume: 27, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Male; Mice; Peritoneal Cavity; Shock; Thiadiazoles; Zymosan

2007
Beneficial effects of erythropoietin in preclinical models of shock and organ failure.
    Critical care (London, England), 2007, Volume: 11, Issue:3

    Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxemia; Erythropoietin; Mice; Multiple Organ Failure; Shock; Shock, Hemorrhagic; Shock, Septic; Spinal Cord Injuries; Treatment Outcome; Zymosan

2007
Etoposide attenuates zymosan-induced shock in mice.
    Inflammation, 2008, Volume: 31, Issue:1

    Topics: Animals; Antineoplastic Agents, Phytogenic; Etoposide; Inflammation; Liver; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, SCID; Organ Size; Sepsis; Shock; Tumor Necrosis Factor-alpha; Zymosan

2008
Properdin deficiency in murine models of nonseptic shock.
    Journal of immunology (Baltimore, Md. : 1950), 2008, May-15, Volume: 180, Issue:10

    Topics: alpha 1-Antitrypsin; Animals; Complement C5a; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Interleukin-10; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Nitric Oxide; Properdin; Shock; Tumor Necrosis Factor-alpha; Zymosan

2008
The adherence of polymorphonuclear leukocytes in patients with sepsis.
    The Journal of infectious diseases, 1982, Volume: 145, Issue:3

    Topics: Adult; Aged; Cell Adhesion; Female; Humans; In Vitro Techniques; Male; Methylprednisolone; Middle Aged; Neutrophils; Plasma; Sepsis; Shock; Time Factors; Zymosan

1982
Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat.
    Shock (Augusta, Ga.), 1997, Volume: 7, Issue:5

    Topics: Acute Disease; Animals; Ascitic Fluid; Blood Pressure; Cardiovascular Diseases; Enzyme Inhibitors; Male; Nitrates; Nitric Oxide; Nitrites; Peritonitis; Rats; Rats, Sprague-Dawley; Shock; Vasomotor System; Zymosan

1997
Peroxynitrate-mediated DNA strand breakage activates poly(ADP-ribose) synthetase and causes cellular energy depletion in a nonseptic shock model induced by zymosan in the rat.
    Shock (Augusta, Ga.), 1998, Volume: 9, Issue:5

    Topics: Animals; Benzamides; Disease Models, Animal; DNA Damage; Energy Metabolism; Enzyme Activation; Macrophages, Peritoneal; Male; Mitochondria; NAD; NG-Nitroarginine Methyl Ester; Niacinamide; Nitrates; Nitric Oxide Synthase; Oxidants; Oxygen Consumption; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Shock; Zymosan

1998
Multiple organ failure (MOF) after severe trauma--a sheep model.
    Intensive care medicine, 1998, Volume: 24, Issue:6

    Topics: Albumins; Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Disease Models, Animal; Disease Progression; Endotoxins; Female; Femur; Fracture Fixation, Intramedullary; Heart Function Tests; Least-Squares Analysis; Leukocyte Count; Liver; Lung; Multiple Organ Failure; Multiple Trauma; Sheep; Shock; Zymosan

1998
Protective effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in a non-septic shock model induced by zymosan in the rat.
    Journal of pineal research, 1998, Volume: 25, Issue:2

    Topics: Animals; Cell Respiration; Cells, Cultured; DNA Damage; Energy Metabolism; Enzyme Activation; Macrophages, Peritoneal; Male; Melatonin; NAD; Nitrates; Nitric Oxide; Oxidation-Reduction; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Rhodamines; Shock; Zymosan

1998
Effects of hyperbaric oxygen exposure on a zymosan-induced shock model.
    Critical care medicine, 1998, Volume: 26, Issue:12

    Topics: Animals; Disease Models, Animal; Hyperbaric Oxygenation; Male; Nitric Oxide; Random Allocation; Rats; Rats, Sprague-Dawley; Shock; Survival Analysis; Time Factors; Tumor Necrosis Factor-alpha; Zymosan

1998
Protective effect of N-acetylcysteine on cellular energy depletion in a non-septic shock model induced by zymosan in the rat.
    Shock (Augusta, Ga.), 1999, Volume: 11, Issue:2

    Topics: Acetylcysteine; Animals; Cell Membrane Permeability; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Energy Metabolism; Free Radical Scavengers; Macrophages, Peritoneal; Male; NAD; Nitrates; Nitric Oxide; Rats; Rats, Sprague-Dawley; Sepsis; Shock; Tyrosine; Zymosan

1999
Role of interleukin-6 in a non-septic shock model induced by zymosan.
    European cytokine network, 1999, Volume: 10, Issue:2

    Topics: Animals; Antibodies, Monoclonal; Ascites; Ascitic Fluid; DNA Damage; Energy Metabolism; Injections, Intraperitoneal; Interleukin-6; Intestine, Small; Leukocyte Count; Lipid Peroxidation; Liver; Lung; Macrophage Activation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Organ Failure; NAD; Neutrophils; Nitrates; Nitrites; Oxidative Phosphorylation; Peritonitis; Peroxidase; Shock; Tyrosine; Zymosan

1999
Role of melatonin in reduction of lipid peroxidation and peroxynitrite formation in non-septic shock induced by zymosan.
    Shock (Augusta, Ga.), 1999, Volume: 12, Issue:5

    Topics: Animals; Antioxidants; Disease Models, Animal; Exudates and Transudates; Immunohistochemistry; Kidney; Lipid Peroxidation; Liver; Lung; Male; Malondialdehyde; Melatonin; Nitrates; Rats; Rats, Sprague-Dawley; Shock; Tyrosine; Zymosan

1999
Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide dismutase mimetic, in zymosan-induced shock.
    British journal of pharmacology, 1999, Volume: 128, Issue:6

    Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Bilirubin; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Energy Metabolism; Free Radical Scavengers; Immunohistochemistry; L-Lactate Dehydrogenase; Lung; Male; Malondialdehyde; Metalloporphyrins; NAD; Nitrates; Peroxidase; Rats; Rats, Sprague-Dawley; Shock; Superoxide Dismutase; Tyrosine; Zymosan

1999
Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
    Shock (Augusta, Ga.), 2001, Volume: 16, Issue:1

    Topics: Animals; Enzyme Inhibitors; Exudates and Transudates; Guanidines; Lipid Peroxidation; Liver; Lung; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Multiple Organ Failure; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Peritonitis; Peroxidase; Poly(ADP-ribose) Polymerases; Rhodamines; Shock; Tyrosine; Zymosan

2001
Protection against superior mesenteric artery occlusion shock by soluble and nonsoluble reticuloendothelial stimulants.
    Advances in shock research, 1978, Volume: 1

    Topics: Animals; Dogs; Enzymes; Female; Hemodynamics; Levamisole; Male; Mesenteric Arteries; Mesenteric Vascular Occlusion; Mononuclear Phagocyte System; Oxygen Consumption; Shock; Zymosan

1978
Age-related alterations in superoxide anion generation in mouse peritoneal macrophages studied by repeated stimulations and heat shock treatment.
    Journal of cellular physiology, 1992, Volume: 152, Issue:2

    Topics: Aging; Animals; Female; Hot Temperature; Macrophages; Mice; NADH, NADPH Oxidoreductases; NADPH Oxidases; Oxygen; Peritoneal Cavity; Respiratory Burst; Shock; Stimulation, Chemical; Superoxide Dismutase; Superoxides; Tetradecanoylphorbol Acetate; Zymosan

1992
SOD in rat models of shock and organ failure.
    Advances in experimental medicine and biology, 1990, Volume: 264

    Topics: Animals; Body Weight; Cattle; Disease Models, Animal; Lipid Peroxidation; Liver; Male; Multiple Organ Failure; Peritonitis; Rats; Rats, Inbred Strains; Shock; Shock, Septic; Superoxide Dismutase; Zymosan

1990